HHMI scientists have designed a potential cancer therapy that uses a unique strategy to block a molecule that drives the growth of cancer.
HHMI researchers identify a potential Achilles heel in the oncogene K-Ras.
Scientists have discovered that an active ingredient in an over-the-counter skin cream slows or stops the effects of Parkinson’s disease on brain cells.
Using chemical genetics to single out a single kinase among the hundreds inside a cell, scientists have gleaned new information about how one such protein might contribute to cancer-promoting signaling.
Researchers have devised clever techniques to visualize gene silencing in its natural context.
Researchers have begun scouring cancer cells for potential sites of resistance against a new class of drugs.
New details emerge about how cells decide their fates when faced with stress.
A new panel of compounds may be a powerful tool to evaluate cellular enzymes as potential targets for drug design.